To study histopathological features, GFAP staining and Ki 67/ MIB-1 labelling index in diagnoses and histological grading of gliomas

---

Original Article

Author Details : Kavita Verma*, Satya Raj Negi, Sanjay Garhwal

Volume : 8, Issue : 2, Year : 2021

Article Page : 115-119

https://doi.org/10.18231/j.ijfcm.2021.023

Suggest article by email

---

Abstract

Background: A group of tumors that develops in the brain and spinal cord is called glioma. Histologically gliomas are classified into astrocytoma, ependymoma, oligodendroglioma, brain stem glioma and oligoastrocytoma. The present study was conducted to study histological grading of gliomas and correlate it with patient’s age, sex, GFAP staining, role of the Ki-67/MIB-1 labelling indices (PIs).
Materials and Methods: The present retrospective study was conducted on 50 biopsies received. All specimens were subjected to immunohistochemistory for GFAP and MIB-1 and correlated with WHO grading for glioma.
Results: High incidence of glial tumours was seen in the 3 and 4 decade with slight male predominance (60%), with commonest site being frontal lobe. Glioblastomas (Grade IV) constitute the most common glial tumour. A statistically significant correlation was observed between GFAP staining and Ki-67/MIB-1 with histological grading.
Conclusion: The study can prove helpful in diagnosis and histological grading of gliomas and in planning treatment protocols and strategies.
 

Keywords: Glioma, GFAP staining, Ki-67/MIB-1 labelling, Histopathological grading.

How to cite : Verma K, Negi S R, Garhwal S, To study histopathological features, GFAP staining and Ki 67/ MIB-1 labelling index in diagnoses and histological grading of gliomas. Indian J Forensic Community Med 2021;8(2):115-119

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.